 | • レポートコード：MRC2312MG11168 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のショートペプチド経腸栄養剤市場規模と予測を収録しています。・世界のショートペプチド経腸栄養剤市場：売上、2018年-2023年、2024年-2029年 ・世界のショートペプチド経腸栄養剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のショートペプチド経腸栄養剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「粉末」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ショートペプチド経腸栄養剤のグローバル主要企業は、Hospira Inc、 Fresenius Kabi、 Danone、 Knowmedical、 Nestlé、 B. Braun Melsungen AG、 Abbott、 Otsuka Pharmaceutical India Private Limited、 NUTRICHEM DIÄT + PHARMA GMBH、 Delta Drugs、 Baxter、 Allergan、 Actavis Inc.、 Grifols, S.A.、 Vifor Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ショートペプチド経腸栄養剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のショートペプチド経腸栄養剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のショートペプチド経腸栄養剤市場：タイプ別市場シェア、2022年 ・粉末、懸濁液、乳液、その他 世界のショートペプチド経腸栄養剤市場：用途別、2018年-2023年、2024年-2029年 世界のショートペプチド経腸栄養剤市場：用途別市場シェア、2022年 ・病原性疾患、栄養不足疾患、遺伝性疾患、精神性疾患、その他 世界のショートペプチド経腸栄養剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のショートペプチド経腸栄養剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるショートペプチド経腸栄養剤のグローバル売上、2018年-2023年 ・主要企業におけるショートペプチド経腸栄養剤のグローバル売上シェア、2022年 ・主要企業におけるショートペプチド経腸栄養剤のグローバル販売量、2018年-2023年 ・主要企業におけるショートペプチド経腸栄養剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Hospira Inc、 Fresenius Kabi、 Danone、 Knowmedical、 Nestlé、 B. Braun Melsungen AG、 Abbott、 Otsuka Pharmaceutical India Private Limited、 NUTRICHEM DIÄT + PHARMA GMBH、 Delta Drugs、 Baxter、 Allergan、 Actavis Inc.、 Grifols, S.A.、 Vifor Pharma ************************************************************* ・調査・分析レポートの概要 ショートペプチド経腸栄養剤市場の定義 市場セグメント 世界のショートペプチド経腸栄養剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のショートペプチド経腸栄養剤市場規模 世界のショートペプチド経腸栄養剤市場規模：2022年 VS 2029年 世界のショートペプチド経腸栄養剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのショートペプチド経腸栄養剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のショートペプチド経腸栄養剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：粉末、懸濁液、乳液、その他 ショートペプチド経腸栄養剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病原性疾患、栄養不足疾患、遺伝性疾患、精神性疾患、その他 ショートペプチド経腸栄養剤の用途別グローバル売上・予測 ・地域別市場分析 地域別ショートペプチド経腸栄養剤市場規模 2022年と2029年 地域別ショートペプチド経腸栄養剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Hospira Inc、 Fresenius Kabi、 Danone、 Knowmedical、 Nestlé、 B. Braun Melsungen AG、 Abbott、 Otsuka Pharmaceutical India Private Limited、 NUTRICHEM DIÄT + PHARMA GMBH、 Delta Drugs、 Baxter、 Allergan、 Actavis Inc.、 Grifols, S.A.、 Vifor Pharma ... |
This research report provides a comprehensive analysis of the Short Peptide Enteral Nutrition market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Short Peptide Enteral Nutrition market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Short Peptide Enteral Nutrition, challenges faced by the industry, and potential opportunities for market players.
The global Short Peptide Enteral Nutrition market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Short Peptide Enteral Nutrition market presents opportunities for various stakeholders, including Pathogenic Diseases, Nutritional Deficiency Diseases. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Short Peptide Enteral Nutrition market. Additionally, the growing consumer demand present avenues for market expansion.
The global Short Peptide Enteral Nutrition market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Short Peptide Enteral Nutrition market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Short Peptide Enteral Nutrition market.
Market Overview: The report provides a comprehensive overview of the Short Peptide Enteral Nutrition market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Powdered Type, Suspension Type), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Short Peptide Enteral Nutrition market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Short Peptide Enteral Nutrition market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Short Peptide Enteral Nutrition market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Short Peptide Enteral Nutrition market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Short Peptide Enteral Nutrition market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Short Peptide Enteral Nutrition market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Short Peptide Enteral Nutrition, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Short Peptide Enteral Nutrition market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Short Peptide Enteral Nutrition market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Powdered Type
Suspension Type
Emulsion Type
Others
Market segment by Application
Pathogenic Diseases
Nutritional Deficiency Diseases
Genetic Diseases
Psychological Diseases
Other
Global Short Peptide Enteral Nutrition Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Hospira Inc
Fresenius Kabi
Danone
Knowmedical
Nestlé
B. Braun Melsungen AG
Abbott
Otsuka Pharmaceutical India Private Limited
NUTRICHEM DIÄT + PHARMA GMBH
Delta Drugs
Baxter
Allergan
Actavis Inc.
Grifols, S.A.
Vifor Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Short Peptide Enteral Nutrition, market overview.
Chapter 2: Global Short Peptide Enteral Nutrition market size in revenue and volume.
Chapter 3: Detailed analysis of Short Peptide Enteral Nutrition manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Short Peptide Enteral Nutrition in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Short Peptide Enteral Nutrition capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Short Peptide Enteral Nutrition Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Short Peptide Enteral Nutrition Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Short Peptide Enteral Nutrition Overall Market Size
2.1 Global Short Peptide Enteral Nutrition Market Size: 2022 VS 2029
2.2 Global Short Peptide Enteral Nutrition Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Short Peptide Enteral Nutrition Sales: 2018-2029
3 Company Landscape
3.1 Top Short Peptide Enteral Nutrition Players in Global Market
3.2 Top Global Short Peptide Enteral Nutrition Companies Ranked by Revenue
3.3 Global Short Peptide Enteral Nutrition Revenue by Companies
3.4 Global Short Peptide Enteral Nutrition Sales by Companies
3.5 Global Short Peptide Enteral Nutrition Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Short Peptide Enteral Nutrition Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Short Peptide Enteral Nutrition Product Type
3.8 Tier 1, Tier 2 and Tier 3 Short Peptide Enteral Nutrition Players in Global Market
3.8.1 List of Global Tier 1 Short Peptide Enteral Nutrition Companies
3.8.2 List of Global Tier 2 and Tier 3 Short Peptide Enteral Nutrition Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Short Peptide Enteral Nutrition Market Size Markets, 2022 & 2029
4.1.2 Powdered Type
4.1.3 Suspension Type
4.1.4 Emulsion Type
4.1.5 Others
4.2 By Type – Global Short Peptide Enteral Nutrition Revenue & Forecasts
4.2.1 By Type – Global Short Peptide Enteral Nutrition Revenue, 2018-2023
4.2.2 By Type – Global Short Peptide Enteral Nutrition Revenue, 2024-2029
4.2.3 By Type – Global Short Peptide Enteral Nutrition Revenue Market Share, 2018-2029
4.3 By Type – Global Short Peptide Enteral Nutrition Sales & Forecasts
4.3.1 By Type – Global Short Peptide Enteral Nutrition Sales, 2018-2023
4.3.2 By Type – Global Short Peptide Enteral Nutrition Sales, 2024-2029
4.3.3 By Type – Global Short Peptide Enteral Nutrition Sales Market Share, 2018-2029
4.4 By Type – Global Short Peptide Enteral Nutrition Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Short Peptide Enteral Nutrition Market Size, 2022 & 2029
5.1.2 Pathogenic Diseases
5.1.3 Nutritional Deficiency Diseases
5.1.4 Genetic Diseases
5.1.5 Psychological Diseases
5.1.6 Other
5.2 By Application – Global Short Peptide Enteral Nutrition Revenue & Forecasts
5.2.1 By Application – Global Short Peptide Enteral Nutrition Revenue, 2018-2023
5.2.2 By Application – Global Short Peptide Enteral Nutrition Revenue, 2024-2029
5.2.3 By Application – Global Short Peptide Enteral Nutrition Revenue Market Share, 2018-2029
5.3 By Application – Global Short Peptide Enteral Nutrition Sales & Forecasts
5.3.1 By Application – Global Short Peptide Enteral Nutrition Sales, 2018-2023
5.3.2 By Application – Global Short Peptide Enteral Nutrition Sales, 2024-2029
5.3.3 By Application – Global Short Peptide Enteral Nutrition Sales Market Share, 2018-2029
5.4 By Application – Global Short Peptide Enteral Nutrition Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Short Peptide Enteral Nutrition Market Size, 2022 & 2029
6.2 By Region – Global Short Peptide Enteral Nutrition Revenue & Forecasts
6.2.1 By Region – Global Short Peptide Enteral Nutrition Revenue, 2018-2023
6.2.2 By Region – Global Short Peptide Enteral Nutrition Revenue, 2024-2029
6.2.3 By Region – Global Short Peptide Enteral Nutrition Revenue Market Share, 2018-2029
6.3 By Region – Global Short Peptide Enteral Nutrition Sales & Forecasts
6.3.1 By Region – Global Short Peptide Enteral Nutrition Sales, 2018-2023
6.3.2 By Region – Global Short Peptide Enteral Nutrition Sales, 2024-2029
6.3.3 By Region – Global Short Peptide Enteral Nutrition Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Short Peptide Enteral Nutrition Revenue, 2018-2029
6.4.2 By Country – North America Short Peptide Enteral Nutrition Sales, 2018-2029
6.4.3 US Short Peptide Enteral Nutrition Market Size, 2018-2029
6.4.4 Canada Short Peptide Enteral Nutrition Market Size, 2018-2029
6.4.5 Mexico Short Peptide Enteral Nutrition Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Short Peptide Enteral Nutrition Revenue, 2018-2029
6.5.2 By Country – Europe Short Peptide Enteral Nutrition Sales, 2018-2029
6.5.3 Germany Short Peptide Enteral Nutrition Market Size, 2018-2029
6.5.4 France Short Peptide Enteral Nutrition Market Size, 2018-2029
6.5.5 U.K. Short Peptide Enteral Nutrition Market Size, 2018-2029
6.5.6 Italy Short Peptide Enteral Nutrition Market Size, 2018-2029
6.5.7 Russia Short Peptide Enteral Nutrition Market Size, 2018-2029
6.5.8 Nordic Countries Short Peptide Enteral Nutrition Market Size, 2018-2029
6.5.9 Benelux Short Peptide Enteral Nutrition Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Short Peptide Enteral Nutrition Revenue, 2018-2029
6.6.2 By Region – Asia Short Peptide Enteral Nutrition Sales, 2018-2029
6.6.3 China Short Peptide Enteral Nutrition Market Size, 2018-2029
6.6.4 Japan Short Peptide Enteral Nutrition Market Size, 2018-2029
6.6.5 South Korea Short Peptide Enteral Nutrition Market Size, 2018-2029
6.6.6 Southeast Asia Short Peptide Enteral Nutrition Market Size, 2018-2029
6.6.7 India Short Peptide Enteral Nutrition Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Short Peptide Enteral Nutrition Revenue, 2018-2029
6.7.2 By Country – South America Short Peptide Enteral Nutrition Sales, 2018-2029
6.7.3 Brazil Short Peptide Enteral Nutrition Market Size, 2018-2029
6.7.4 Argentina Short Peptide Enteral Nutrition Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Short Peptide Enteral Nutrition Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Short Peptide Enteral Nutrition Sales, 2018-2029
6.8.3 Turkey Short Peptide Enteral Nutrition Market Size, 2018-2029
6.8.4 Israel Short Peptide Enteral Nutrition Market Size, 2018-2029
6.8.5 Saudi Arabia Short Peptide Enteral Nutrition Market Size, 2018-2029
6.8.6 UAE Short Peptide Enteral Nutrition Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hospira Inc
7.1.1 Hospira Inc Company Summary
7.1.2 Hospira Inc Business Overview
7.1.3 Hospira Inc Short Peptide Enteral Nutrition Major Product Offerings
7.1.4 Hospira Inc Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.1.5 Hospira Inc Key News & Latest Developments
7.2 Fresenius Kabi
7.2.1 Fresenius Kabi Company Summary
7.2.2 Fresenius Kabi Business Overview
7.2.3 Fresenius Kabi Short Peptide Enteral Nutrition Major Product Offerings
7.2.4 Fresenius Kabi Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.2.5 Fresenius Kabi Key News & Latest Developments
7.3 Danone
7.3.1 Danone Company Summary
7.3.2 Danone Business Overview
7.3.3 Danone Short Peptide Enteral Nutrition Major Product Offerings
7.3.4 Danone Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.3.5 Danone Key News & Latest Developments
7.4 Knowmedical
7.4.1 Knowmedical Company Summary
7.4.2 Knowmedical Business Overview
7.4.3 Knowmedical Short Peptide Enteral Nutrition Major Product Offerings
7.4.4 Knowmedical Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.4.5 Knowmedical Key News & Latest Developments
7.5 Nestlé
7.5.1 Nestlé Company Summary
7.5.2 Nestlé Business Overview
7.5.3 Nestlé Short Peptide Enteral Nutrition Major Product Offerings
7.5.4 Nestlé Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.5.5 Nestlé Key News & Latest Developments
7.6 B. Braun Melsungen AG
7.6.1 B. Braun Melsungen AG Company Summary
7.6.2 B. Braun Melsungen AG Business Overview
7.6.3 B. Braun Melsungen AG Short Peptide Enteral Nutrition Major Product Offerings
7.6.4 B. Braun Melsungen AG Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.6.5 B. Braun Melsungen AG Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Short Peptide Enteral Nutrition Major Product Offerings
7.7.4 Abbott Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.7.5 Abbott Key News & Latest Developments
7.8 Otsuka Pharmaceutical India Private Limited
7.8.1 Otsuka Pharmaceutical India Private Limited Company Summary
7.8.2 Otsuka Pharmaceutical India Private Limited Business Overview
7.8.3 Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Major Product Offerings
7.8.4 Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.8.5 Otsuka Pharmaceutical India Private Limited Key News & Latest Developments
7.9 NUTRICHEM DIÄT + PHARMA GMBH
7.9.1 NUTRICHEM DIÄT + PHARMA GMBH Company Summary
7.9.2 NUTRICHEM DIÄT + PHARMA GMBH Business Overview
7.9.3 NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Major Product Offerings
7.9.4 NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.9.5 NUTRICHEM DIÄT + PHARMA GMBH Key News & Latest Developments
7.10 Delta Drugs
7.10.1 Delta Drugs Company Summary
7.10.2 Delta Drugs Business Overview
7.10.3 Delta Drugs Short Peptide Enteral Nutrition Major Product Offerings
7.10.4 Delta Drugs Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.10.5 Delta Drugs Key News & Latest Developments
7.11 Baxter
7.11.1 Baxter Company Summary
7.11.2 Baxter Business Overview
7.11.3 Baxter Short Peptide Enteral Nutrition Major Product Offerings
7.11.4 Baxter Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.11.5 Baxter Key News & Latest Developments
7.12 Allergan
7.12.1 Allergan Company Summary
7.12.2 Allergan Business Overview
7.12.3 Allergan Short Peptide Enteral Nutrition Major Product Offerings
7.12.4 Allergan Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.12.5 Allergan Key News & Latest Developments
7.13 Actavis Inc.
7.13.1 Actavis Inc. Company Summary
7.13.2 Actavis Inc. Business Overview
7.13.3 Actavis Inc. Short Peptide Enteral Nutrition Major Product Offerings
7.13.4 Actavis Inc. Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.13.5 Actavis Inc. Key News & Latest Developments
7.14 Grifols, S.A.
7.14.1 Grifols, S.A. Company Summary
7.14.2 Grifols, S.A. Business Overview
7.14.3 Grifols, S.A. Short Peptide Enteral Nutrition Major Product Offerings
7.14.4 Grifols, S.A. Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.14.5 Grifols, S.A. Key News & Latest Developments
7.15 Vifor Pharma
7.15.1 Vifor Pharma Company Summary
7.15.2 Vifor Pharma Business Overview
7.15.3 Vifor Pharma Short Peptide Enteral Nutrition Major Product Offerings
7.15.4 Vifor Pharma Short Peptide Enteral Nutrition Sales and Revenue in Global (2018-2023)
7.15.5 Vifor Pharma Key News & Latest Developments
8 Global Short Peptide Enteral Nutrition Production Capacity, Analysis
8.1 Global Short Peptide Enteral Nutrition Production Capacity, 2018-2029
8.2 Short Peptide Enteral Nutrition Production Capacity of Key Manufacturers in Global Market
8.3 Global Short Peptide Enteral Nutrition Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Short Peptide Enteral Nutrition Supply Chain Analysis
10.1 Short Peptide Enteral Nutrition Industry Value Chain
10.2 Short Peptide Enteral Nutrition Upstream Market
10.3 Short Peptide Enteral Nutrition Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Short Peptide Enteral Nutrition Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
